480789
Bismuth(III) subsalicylate
99.9% trace metals basis
동의어(들):
Bismuth oxysalicylate, Bismuth subsalicylate, Bismuth(III) salicylate basic
로그인조직 및 계약 가격 보기
모든 사진(3)
크기 선택
보기 변경
100 G
₩61,306
500 G
₩144,536
About This Item
Linear Formula:
HOC6H4COOBiO
CAS Number:
Molecular Weight:
362.09
EC Number:
MDL number:
UNSPSC 코드:
12161600
PubChem Substance ID:
NACRES:
NA.22
추천 제품
Quality Level
분석
99.9% trace metals basis
반응 적합성
core: bismuth
reagent type: catalyst
mp
>350 °C (lit.)
SMILES string
O[Bi]1OC(=O)c2ccccc2O1
InChI
1S/C7H6O3.Bi.H2O/c8-6-4-2-1-3-5(6)7(9)10;;/h1-4,8H,(H,9,10);;1H2/q;+3;/p-3
InChI key
ZREIPSZUJIFJNP-UHFFFAOYSA-K
일반 설명
애플리케이션
- Use of ferric chloride to identify salicylate-containing poisons.: This study explores the use of ferric chloride to detect salicylate compounds, including Bismuth subsalicylate, highlighting its significance in toxicological screenings and emergency treatments. (Hoffman RJ et al., 2002).
- Effect of pepper and bismuth subsalicylate on gastric pain and surface hydrophobicity in the rat.: Investigates the effects of Bismuth subsalicylate on gastric pain and stomach lining properties, providing insights into its gastroprotective mechanisms. (Lichtenberger LM et al., 1998).
- The coccoid forms of Helicobacter pylori. Criteria for their viability.: Examines the effectiveness of Bismuth subsalicylate in targeting different morphological forms of Helicobacter pylori, contributing to its role in eradication therapies. (Bode G et al., 1993).
- Bismuth therapy in gastrointestinal diseases.: A comprehensive review of the therapeutic applications of Bismuth subsalicylate in treating various gastrointestinal disorders, underscoring its pharmacological benefits and safety profile. (Gorbach SL, 1990).
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
개인 보호 장비
Eyeshields, Gloves, type N95 (US)
이미 열람한 고객
D W Bierer
Reviews of infectious diseases, 12 Suppl 1, S3-S8 (1990-01-01)
Pepto-Bismol, which contains bismuth subsalicylate (BSS) as the active ingredient, has been marketed in the United States for more than 80 years. In the gastrointestinal tract, BSS is converted to salicylic acid and insoluble bismuth salts. The salicylate portion of
Copolymerizations of e-Caprolactone and Glycolide A Comparison of Tin (II) Octanoate and Bismuth (III) Subsalicylate as Initiators.
Kricheldorf HR and Rost S.
Biomolecules, 6(3), 1345-1352 (2005)
Raúl León Barúa
Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru, 30(2), 148-152 (2010-07-21)
In the present paper, the author reminds investigations performed, since forty-four years ago, to clarify the etiopathogenesis and to improve the diagnosis and treatment of the flatulence syndrome.
A E Jergens et al.
Journal of veterinary internal medicine, 23(1), 16-23 (2009-01-30)
The results of studies examining the role of Helicobacter spp. in the pathogenesis of canine and feline gastritis are inconclusive. Furthermore, data evaluating the effectiveness of medical therapy for eradication of Helicobacter infection are limited. To detect Helicobacter spp. in
Lori A Spies
Journal of midwifery & women's health, 53(3), 251-254 (2008-05-06)
Traveler's diarrhea is a condition that disrupts work and vacation, and affects many women traveling from developed countries to developing countries. Specific food and hygiene education may help to decrease the occurrence of this common food and water-borne gastrointestinal infection.
활성 필터
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.
